Home/ Supplements/ Phosphorus/ Fem'O'Vita

Fem'O'Vita

product on market Powder Holin Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 31% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The listed ingredients consist of basic macronutrients and minerals rather than targeted active compounds. There is strong evidence that these components are essential for general metabolic function, though they do not provide specific therapeutic benefits. Evidence coverage for this particular formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Fem'O'Vita
Open Full PDF View on NIH DSLD →
Details

Label Data

20 Gram(s)
Serving Size
20
Servings
Botanical with Nutrients
Product Type
31%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
82.8 Calorie(s)
Total Fat
1.46 Gram(s) (4.86% DV)
Cholesterol
Sodium
9.73 mg (0.48% DV)
Total Carbohydrates
15 Gram(s) (15% DV)
Dietary Fiber
3.15 Gram(s) (7.88% DV)
Protein
2.4 Gram(s) (4.36% DV)
Iron
3.46 mg (18.2% DV)
Calcium
49.56 mg (4.95% DV)
0.12 mg (5.46% DV)
Within RDA (0.1× RDA) 37 studies (A:0, B:11)
37.16 mg (8.44% DV)
Within RDA (0.1× RDA) 316 studies (A:8, B:159)
2 mcg (1.33% DV)
Market median: 0.27mg (318 products) 245 studies (A:4, B:133)
68.75 mg (1.95% DV)
Within RDA (0.1× RDA) 13 studies (A:0, B:3)
Potassium
117.75 mg (11.77% DV)
0.4 mg (2.38% DV)
Market median: 18.0mg (1009 products) 263 studies (A:6, B:134)
Blend
20 Gram(s)

Other Ingredients

Flavoring Benzoate Sorbate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Direction for use Oral consumption only 20gm twice a day, preferably with 200ml of milk or water. Mix it thoroughly so that there are no lumps formed and you get a homogenous mixture.

Warnings & Precautions

Do not consume more than recommended daily usage. Not for medicinal use Femovita can be consumed without medical supervision.

Children under 5 years should not take adolescents shall use it, strictly under instructions from health advisor.

Do not consume if the container is damaged, puffed or there is any leakage.

Contains gluten and soya

Formulation Notes

Product of India

Safe & strong Helps build immunity as well as physical and emotional "well being"

Wellness for women Food for women wellness

Plant based

Non GMO

Vegan friendly

FSSAI No: 12419023000636

Additional Information

Best before 12 months from manufacture

For feed back / complaints E-mail : care@holinovita.com You can also buy this product on: www.holinovita.in

Storage instruction Store the container in dry, cool place in hygienic condition, away from sunlight. Deep freeze not required.

6 dimensions Nutrition made simple Transforming health in every direction Lets go green

Metadata

Product Details

DSLD Entry Date2024-01-24
Product TypeBotanical with Nutrients
FormPowder
BrandHolin
DSLD ID306050
Data Updated2026-04-11
Research

Research Evidence

46
Research Sources
55
Avg Quality
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020 PubMed DOI
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018 PubMed DOI
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022 PubMed DOI
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022 PubMed DOI
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024 PubMed DOI
View all evidence for Phosphorus →
Compare

Similar Products

View all Phosphorus products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.